SLC5A2 and myocardial infarction: Lastly, some antidiabetics such as metformin [37], glucagon-like peptide 1 (GLP-1; incretins) analogs [38,39], or SGLT2 (Sodium-glucose cotransporter 2) inhibitors [40,41] are known to have a favorable effect against myocardial infarction.